NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered Retatrutide from Shanghai Sigma Audley SSA? Mail in a sample (US only) and let us test it.

Test my supply
+5 more ↓
80%
Finnrick rating
#84 of 419 Retatrutide vendors
67 of 83 classifiable tests passed
customers 3.9★ (9)
methodology · Purity focus
Finnrick analysis · Retatrutide

Shanghai Sigma Audley SSA retatrutide's purity-focused rating reflects volatility, not a steady profile. After a recovery from earlier misses, the latest lab record failed identity; outliers include 97.86% purity and -89%/+54%/-44% fills.

methodology →
vendor intelligence report
Vendor Intelligence Report: Shanghai Sigma Audley SSA

Chinese registry records, clone-site code, and an Oath checkout trail show SSA-branded buying paths do not line up with the Shanghai seller named in the terms. The report maps fake verifier sites, Trustpilot-style reviews, precursor listings, and the unresolved clone operator.

40 pages8 risk factors assessed12 Nov 2026
read the report
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%9 Jun 2025: 62%20 Jun 2025: 64%30 Jun 2025: 67%30 Jun 2025: 69%3 Jul 2025: 72%16 Jul 2025: 73%17 Jul 2025: 75%24 Jul 2025: 72%24 Jul 2025: 74%24 Jul 2025: 76%25 Jul 2025: 73%25 Jul 2025: 74%25 Jul 2025: 76%25 Jul 2025: 77%4 Aug 2025: 74%4 Aug 2025: 75%4 Aug 2025: 72%6 Aug 2025: 69%6 Aug 2025: 71%11 Aug 2025: 72%11 Aug 2025: 73%11 Aug 2025: 74%12 Aug 2025: 75%14 Aug 2025: 76%14 Aug 2025: 77%21 Aug 2025: 78%21 Aug 2025: 79%21 Aug 2025: 80%21 Aug 2025: 80%21 Aug 2025: 81%31 Aug 2025: 82%1 Sep 2025: 82%1 Sep 2025: 83%4 Sep 2025: 83%4 Sep 2025: 84%4 Sep 2025: 84%10 Sep 2025: 85%10 Sep 2025: 83%10 Sep 2025: 81%10 Sep 2025: 79%10 Sep 2025: 79%18 Sep 2025: 80%18 Sep 2025: 80%18 Sep 2025: 81%30 Sep 2025: 81%30 Sep 2025: 82%5 Oct 2025: 80%5 Oct 2025: 81%5 Oct 2025: 81%5 Oct 2025: 81%5 Oct 2025: 82%9 Oct 2025: 82%9 Oct 2025: 83%9 Oct 2025: 83%13 Oct 2025: 83%13 Oct 2025: 83%17 Oct 2025: 84%17 Oct 2025: 84%21 Oct 2025: 83%23 Oct 2025: 81%23 Oct 2025: 80%23 Oct 2025: 79%24 Oct 2025: 79%24 Oct 2025: 79%24 Oct 2025: 80%30 Oct 2025: 80%4 Nov 2025: 80%6 Nov 2025: 81%17 Nov 2025: 79%23 Nov 2025: 78%25 Nov 2025: 78%13 Dec 2025: 79%29 Dec 2025: 79%26 Jan 2026: 80%3 Mar 2026: 80%3 Mar 2026: 80%10 Mar 2026: 80%10 Mar 2026: 81%10 Mar 2026: 81%18 Mar 2026: 81%19 Mar 2026: 82%5 May 2026: 82%18 Sep 2026: 80%15 Nov 2026: current 80%62%79%80%Jun 25Nov 26
Showing Retatrutide tests only
Peptide testing

Ordered Retatrutide from Shanghai Sigma Audley SSA? Mail in a sample (US only) and let us test it.

Test my supply
Shanghai Sigma Audley SSA Retatrutide test history
COA-backed lab tests
1-10 of 83

About Shanghai Sigma Audley SSA test results from Finnrick

Shanghai Sigma Audley SSA is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 13 peptides and 228 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Shanghai Sigma Audley SSA peptides in this dataset are BPC-157 (14 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 200 recent tests.

Corrections
No corrections.
Peptide testing

Ordered Retatrutide from Shanghai Sigma Audley SSA? Mail in a sample (US only) and let us test it.

Test my supply